Upgrade to SI Premium - Free Trial

Celldex Therapeutics (CLDX) PT Raised to $50 at H.C. Wainwright

July 12, 2021 6:21 AM
H.C. Wainwright analyst Joseph Pantginis raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $50.00 (from $36.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles